お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
242614

心停止:世界の治験動向

Cardiac Arrest Global Clinical Trials Review, H2, 2018

出版日: | 発行: GlobalData | ページ情報: 英文 91 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.75円
心停止:世界の治験動向
出版日: 2018年12月31日
発行: GlobalData
ページ情報: 英文 91 Pages
納期: 即納可能 即納可能とは
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、心停止に関連する治験の動向を調査しており、治験件数および被験者数、段階別の状況、有望企業、開発中の治療薬の情報、治験プロファイルなどについて、体系的な情報を提供しています。

当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要5ヶ国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東・アフリカの主要国における治験件数

G7諸国での治験件数:心血管疾患治療薬の治験における心停止の割合

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:心血管疾患治療薬の治験における心停止の割合

E7諸国における段階別の治験件数

E7諸国での治験件数:進捗状況別

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

心停止関連の治験に携わっている主要企業

有望な薬剤

治験プロファイルの概要

付録

図表

List of Tables

  • Cardiac Arrest Therapeutics, Global, Clinical Trials by Region, 2018* 7
  • Cardiac Arrest Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
  • Cardiac Arrest Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
  • Cardiac Arrest Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 11
  • Cardiac Arrest Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12
  • Cardiac Arrest Therapeutics Clinical Trials, North America, Top Countries, 2018* 13
  • Cardiac Arrest Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2018* 14
  • Proportion of Cardiac Arrest to Cardiovascular Clinical Trials, G7 Countries (%), 2018* 15
  • Cardiac Arrest Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 16
  • Cardiac Arrest Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 17
  • Proportion of Cardiac Arrest to Cardiovascular Clinical Trials, E7 Countries (%), 2018* 18
  • Cardiac Arrest Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 19
  • Cardiac Arrest Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 20
  • Cardiac Arrest Therapeutics, Global, Clinical Trials by Phase, 2018* 21
  • Cardiac Arrest Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 22
  • Cardiac Arrest Therapeutics, Global, Clinical Trials by Trial Status, 2018* 24
  • Cardiac Arrest Therapeutics Clinical Trials, Global, by End Point Status, 2018* 25
  • Cardiac Arrest Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 26
  • Cardiac Arrest Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 27
  • Cardiac Arrest Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 29
  • Cardiac Arrest Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 31
  • Cardiac Arrest Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 32

List of Figures

  • Cardiac Arrest Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
  • Cardiac Arrest Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
  • Cardiac Arrest Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
  • Cardiac Arrest Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 11
  • Cardiac Arrest Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12
  • Cardiac Arrest Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 13
  • Cardiac Arrest Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2018* 14
  • Proportion of Cardiac Arrest to Cardiovascular Clinical Trials, G7 Countries (%), 2018* 15
  • Cardiac Arrest Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 16
  • Cardiac Arrest Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 17
  • Proportion of Cardiac Arrest to Cardiovascular Clinical Trials, E7 Countries (%), 2018* 18
  • Cardiac Arrest Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 19
  • Cardiac Arrest Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 20
  • Cardiac Arrest Therapeutics, Global, Clinical Trials by Phase (%), 2018* 21
  • Cardiac Arrest Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 22
  • Cardiac Arrest Therapeutics, Global, Clinical Trials by Trial Status, 2018* 23
  • Cardiac Arrest Therapeutics Clinical Trials, Global, by End Point Status, 2018* 25
  • Cardiac Arrest Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 26
  • Cardiac Arrest Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 27
  • Cardiac Arrest Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 28
  • Cardiac Arrest Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 30
  • Cardiac Arrest Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 32
  • GlobalData Methodology 90
目次
Product Code: GDHC5520CTIDB

GlobalData's clinical trial report, "Cardiac Arrest Global Clinical Trials Review, H2, 2018" provides an overview of Cardiac Arrest clinical trials scenario. This report provides top line data relating to the clinical trials on Cardiac Arrest. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

  • Table of Contents 2
    • List of Tables 3
    • List of Figures 4
  • Report Guidance 5
  • GlobalData Clinical Trials Report Coverage 6
  • Clinical Trials by Region 7
    • Clinical Trials and Average Enrollment by Country 8
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
      • Top Five Countries Contributing to Clinical Trials in Europe 12
      • Top Countries Contributing to Clinical Trials in North America 13
      • Top Countries Contributing to Clinical Trials in Middle East and Africa 14
  • Clinical Trials by G7 Countries: Proportion of Cardiac Arrest to Cardiovascular Clinical Trials 15
  • Clinical Trials by Phase in G7 Countries 16
  • Clinical Trials in G7 Countries by Trial Status 17
  • Clinical Trials by E7 Countries: Proportion of Cardiac Arrest to Cardiovascular Clinical Trials 18
  • Clinical Trials by Phase in E7 Countries 19
  • Clinical Trials in E7 Countries by Trial Status 20
  • Clinical Trials by Phase 21
    • In Progress Trials by Phase 22
  • Clinical Trials by Trial Status 23
  • Clinical Trials by End Point Status 25
  • Subjects Recruited Over a Period of Time 26
  • Clinical Trials by Sponsor Type 27
  • Prominent Sponsors 28
    • Top Companies Participating in Cardiac Arrest Therapeutics Clinical Trials 30
  • Prominent Drugs 32
  • Clinical Trial Profile Snapshots 33
  • Appendix 89
    • Abbreviations 89
    • Definitions 89
    • Research Methodology 90
    • Secondary Research 90
    • About GlobalData 90
    • Contact Us 91
  • Source 91
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.